Render Target: STATIC
Render Timestamp: 2025-01-22T13:51:49.907Z
Commit: da7e4f2f0d1aed1f1f8e20e4e2ecab8f33cbd595
XML generation date: 2024-09-19 21:57:39.485
Product last modified at: 2025-01-10T13:00:17.995Z
Cell Signaling Technology Logo

Basket Updated

0

Items added

1% for the planet logo
PDP - Template Name: Chemical Modulators
PDP - Template ID: *******c501c72

Dorsomorphin (Compound C) #60887

Dorsomorphin (Compound C): Image 1
Western blot analysis of extracts from C2C12 cells, untreated (-) or treated with combinations of the following treatments as indicated: AICAR #9944 (2 mM, 24 hr; +) and Dorsomorphin (Compound C) (10 μM, 24 hr; +), using Phospho-AMPKα (Thr172) (40H9) Rabbit mAb #2535 (upper), AMPKα Antibody #2532 (middle), or β-Actin (D6A8) Rabbit mAb #8457 (lower).

To Purchase # 60887

Cat. # Size Qty. Price Ships
60887S 5 mg
$122
  • Related Products

Product Information

Product Usage Information

Dorsomorphin (Compound C) is supplied as a lyophilized powder. For a 10 mM stock, reconstitute 5 mg of powder in 1.25 ml of DMSO. Working concentrations and length of treatment can vary depending on the desired effect.

Storage

Store lyophilized at -20ºC, desiccated. In lyophilized form, the chemical is stable for 24 months. Once in solution, store at -20ºC and use within 3 months to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Product Description

Molecular Weight 399.5 g/mol
Purity >98%
Molecular Formula C24H25N5O
CAS 866405-64-3
Solubility Soluble in DMSO at 4 mg/ml with warming.

Background

Dorsomorphin (Compound C) is a potent and reversible AMP-activated protein kinase (AMPK) inhibitor that competes with ATP in the absence of AMP with a Ki value of 109 nM (1). This small compound is selective, displaying no significant inhibition of other kinases inclusive of ZAPK, SYK, PKCθ, PKA, and JAK3 (1). Research has shown that Dorsomorphin (Compound C) inhibits tumor cell proliferation and induces apoptosis through mechanisms independent of the AMPK pathway (2). This compound inhibits the effects that AICAR and metformin have on inactivating acetyl-CoA carboxylase (ACC) and selectively inhibits the BMP type I receptors ALK2, ALK3, and ALK6 (1,3). 
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
All other trademarks are the property of their respective owners. Visit our Trademark Information page.